BrainsWay Ltd. Company

Brainsway's patented breakthrough technology launches a new era in brain disorder treatment.

Total Funding: 65495696.0
Headquarters: Jerusalem, Yerushalayim, Israel
Funding Status: IPO
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity
Last Funding Date: 2021-02-23
Investors Number: 4.0
Founded Date: 2003-01-01
Industry: Neurodegenerative disease diagnosis and treatment